Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Pain 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphoma 1Leukemia 1

Interventions

fludarabine phosphate 16Peripheral Blood Stem Cell Transplantation 16Cyclophosphamide 16Mycophenolic Acid 14Whole-Body Irradiation 13Cyclosporine 12Busulfan 12Tacrolimus 11Methotrexate 10Antilymphocyte Serum 9Etoposide 7Cyclosporins 7Melphalan 6Sirolimus 5Radiotherapy 5Cytarabine 5Filgrastim 4Cord Blood Stem Cell Transplantation 4ruxolitinib 3Rituximab 3Granulocyte Colony-Stimulating Factor 3Alemtuzumab 3thymoglobulin 2sargramostim 2Pentostatin 2Methylprednisolone 2Flow Cytometry 2Carmustine 2Carboplatin 2veliparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Myelodysplastic-Myeloproliferative Diseases × Baclofen × Clear all
NCT00516503 2017-08-24

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
208 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Pain, Neurotoxicity Syndromes, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡